MEN10733

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 蒽环类药物
• 英文名称: MEN10733
• 英文别名: (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione
• 化学式: C₃₃H₃₉NO₁₃
• 分子量: 657.672
• InChiKey: BQQQWRLWLJHWKW-RPYJURNCSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  47
• 可旋转键数：
  6
• 环数：
  6.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  225
• 氢给体数：
  6
• 氢受体数：
  14

反应信息

• 作为产物：
  描述：

  2,3,6-trideoxy-1,4-di-O-p-nitrobenzoyl-3-trifluoroacetamido-L-lyxopyranose 在 吡啶 、 barium dihydroxide 、 ammonium cerium(IV) nitrate 、 三氟甲磺酸三甲基硅酯 、 iodonium di(2,4,6-trimethylpyridine) perchlorate 、 4 A molecular sieve 作用下， 以 甲醇 、 乙醚 、 二氯甲烷 、 水 、 1,2-二氯乙烷 、 乙腈 为溶剂， 反应 21.0h， 生成 MEN10733
  参考文献：
  名称：

  New anthracycline disaccharides. Synthesis ofL-daunosaminyl-α(1 →4)-2-deoxy-L-rhamnosyl and ofL-daunosaminyl-α(1 →4)-2-deoxy-L-fucosyl daunorubicin analogues

  摘要：

  The synthesis of the new disaccharide anthracyclines 20, 21, 24 and 25, where the daunosamine moiety is separated from the aglycone by either a rhamnose or a fucose residue, performed following a convergent procedure, gives insight into the configurational requirement of the first sugar residue and opens the way to a new class of antitumour anthracyclines.

  DOI：

  10.1039/p19960001327

文献信息

• New anthracycline disaccharides. Synthesis of<scp>L</scp>-daunosaminyl-α(1 →4)-2-deoxy-<scp>L</scp>-rhamnosyl and of<scp>L</scp>-daunosaminyl-α(1 →4)-2-deoxy-<scp>L</scp>-fucosyl daunorubicin analogues
  作者：Fabio Animati、Federico Arcamone、Marco Berettoni、Amalia Cipollone、Maurizio Franciotti、Paolo Lombardi

  DOI：10.1039/p19960001327

  日期：——

  The synthesis of the new disaccharide anthracyclines 20, 21, 24 and 25, where the daunosamine moiety is separated from the aglycone by either a rhamnose or a fucose residue, performed following a convergent procedure, gives insight into the configurational requirement of the first sugar residue and opens the way to a new class of antitumour anthracyclines.